Syncona launches Treg company Quell with £35 million A round

Syncona hopes newly launched Treg cell company Quell Therapeutics can generate clinical data on at least one program within the lifespan of

Read the full 221 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE